Latest Articles
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with Endometriosis: Study - Medical Dialogues
Relugolix Combination Therapy Improves Pain, Functioning, and Quality of Life in Women with Endometriosis: Study Medical Dialogues
Published: Nov. 11, 2024, 3:45 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - ca.proactiveinvestors.com
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis ca.proactiveinvestors.com
Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive financial news
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive financial news
Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive Investors USA
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive Investors USA
Published: Oct. 31, 2024, 5:16 p.m.
Chemotherapy Combinations and the Phase 3 DUO-E Trial - Cancer Network
Chemotherapy Combinations and the Phase 3 DUO-E Trial Cancer Network
Published: Oct. 24, 2024, 6:32 p.m.
Revolutionary combination of scanning and surgery helps endometriosis patients - Hamilton Health Sciences
Revolutionary combination of scanning and surgery helps endometriosis patients Hamilton Health Sciences
Published: July 15, 2024, 7 a.m.
Novel immunotherapy combination approved for endometrial cancer - European Pharmaceutical Review
Novel immunotherapy combination approved for endometrial cancer European Pharmaceutical Review
Published: June 18, 2024, 7 a.m.
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central
Published: June 17, 2024, 7 a.m.
Relugolix combination therapy effective, safe for premenopausal women with endometriosis - Healio
Relugolix combination therapy effective, safe for premenopausal women with endometriosis Healio
Published: June 11, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …
Published: May 20, 2024, 7 a.m.
Link copied to clipboard!